Maqui (Aristotelia chilensis)
What Is Maqui?
Maqui is listed botanically as Aristotelia chilensis, a plant of the Elaeocarpaceae family, native to Chile and Argentina. The material in circulation is berry — the fruiting body of the plant. The common name Maqui and the botanical name Aristotelia chilensis refer to the same material, and labels may use either — a detail that matters when related species in the same genus are not interchangeable. Its character is described as deep dark-berry with a tannic finish, which is often how the raw material is checked for quality.
Use of Maqui predates its chemical analysis by a long way: earlier records describe it by season, preparation and the part gathered rather than by any constituent, and that practical knowledge is what later study was measured against. Beyond its practical use it carries cultural associations — Sacred Mapuche berry of strength and peace.
Today most searches for Maqui come from people reading about wound healing, stress relief, eye health and blood sugar, or checking how it sits alongside a medication they already take. The use most often documented in the literature is exceptionally high delphinidin anthocyanin content, followed by studied for tear production in dry eye syndrome.
How Does Maqui Work?
Maqui works as a mixture rather than a single isolated compound, and its profile is usually described by the class of constituents present in berry rather than by one marker molecule.
Before its chemistry was known, Maqui was judged by what it did in the cup: how strongly it brewed, how it tasted, and how little or much was needed. Those notes are why particular preparations survived and others did not.
The research base is developing: there are human trials, though sample sizes and designs vary, and this profile cites 1 source. Reported findings centre on delphinidin-3-sambubioside-5-glucoside dominates; standardised extracts (MaquiBright) have been studied at 30–60 mg/day for tear film stability. Where research exists, it examines exceptionally high delphinidin anthocyanin content, studied for tear production in dry eye syndrome and investigated for post-meal glucose and oxidative stress markers. These are areas of study, not established outcomes, and results differ by preparation and dose.
How the plant is prepared changes what you actually get. Its constituents move readily into water and alcohol — so a preparation made in another medium will not carry the same fraction of the plant, which is why traditional recipes specify one over another.
Maqui is studied as a whole preparation because isolating one fraction tends to behave differently from the material it was taken out of — a recurring finding across the plant-chemistry literature.
Because these constituents are processed by the same pathways that handle many medicines, Maqui is documented as interacting with antidiabetic drugs. That is a question of shared metabolism rather than of potency, and it is the main reason the plant is listed in interaction references at all.
Dose, plant part and growing conditions all shift the constituent profile, so two products carrying the name Maqui can differ substantially; this is why reference entries specify berry and, where they exist, standardisation markers.